Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference40 articles.
1. Discovery and development of GS 4104 (oseltamivir): an orally active influenza neuraminidase inhibitor;Lew;Curr Med Chem,2000
2. Tamiflu. EPAR—product Information. Annex I—European summary of product characteristics. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000402/WC500033106.pdf [accessed 10.12.14].
3. Tamiflu. Highlights of prescribing information. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021087s060,021246s043lbl.pdf [accessed 10.12.14].
4. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group;Treanor;JAMA,2000
5. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group;Nicholson;Lancet,2000
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献